Diagnosis of Hypersensitivity Pneumonitis in Adults: An Official ATS/JRS/ALAT Clinical Practice Guideline

Ganesh Raghu(University of Washington), Martine Rémy‐Jardin(Evaluation des technologies de santé et des pratiques médicales), Christopher J. Ryerson(University of British Columbia), Jeffrey L. Myers(University of Michigan), Michael Kreuter(Heidelberg University), Martina Vašáková, Elena Bargagli(University of Siena), Jonathan H. Chung, Bridget F. Collins, Elisabeth Bendstrup(Aarhus University Hospital), Hassan Chami, Abigail Chua, Tamera J. Corte(The University of Sydney), Jean‐Charles Dalphin(Centre Hospitalier Universitaire de Besançon), Sonye K. Danoff(Johns Hopkins University), Javier Diaz‐Mendoza, Abhijit Duggal(Cleveland Clinic), Ryoko Egashira, T. Ewing, Mridu Gulati, Yoshikazu Inoue(Kindai University), Alex R. Jenkins, Kerri A. Johannson(University of Calgary), Takeshi Johkoh(The University of Osaka), Maximiliano Tamae Kakazu, Masanori Kitaichi, Shandra L. Knight, Dirk Koschel, David J. Lederer, Yolanda Mageto, Lisa A. Maier, Carlos Matiz, Ferrán Morell(Vall d'Hebron Hospital Universitari), Andrew G. Nicholson(Royal Brompton & Harefield NHS Foundation Trust), Setu Patolia, Carlos A.C. Pereira, Elisabetta Renzoni, Margaret L. Salisbury, Moisés Selman, Simon Walsh(Imperial College London), Wim Wuyts(Universitair Ziekenhuis Leuven), Kevin C. Wilson(Boston University)
American Journal of Respiratory and Critical Care Medicine
July 24, 2020
Cited by 1,001Open Access
Full Text

Abstract

Abstract Background This guideline addresses the diagnosis of hypersensitivity pneumonitis (HP). It represents a collaborative effort among the American Thoracic Society, Japanese Respiratory Society, and Asociación Latinoamericana del Tórax. Methods Systematic reviews were performed for six questions. The evidence was discussed, and then recommendations were formulated by a multidisciplinary committee of experts in the field of interstitial lung disease and HP using the GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) approach. Results The guideline committee defined HP, and clinical, radiographic, and pathological features were described. HP was classified into nonfibrotic and fibrotic phenotypes. There was limited evidence that was directly applicable to all questions. The need for a thorough history and a validated questionnaire to identify potential exposures was agreed on. Serum IgG testing against potential antigens associated with HP was suggested to identify potential exposures. For patients with nonfibrotic HP, a recommendation was made in favor of obtaining bronchoalveolar lavage (BAL) fluid for lymphocyte cellular analysis, and suggestions for transbronchial lung biopsy and surgical lung biopsy were also made. For patients with fibrotic HP, suggestions were made in favor of obtaining BAL for lymphocyte cellular analysis, transbronchial lung cryobiopsy, and surgical lung biopsy. Diagnostic criteria were established, and a diagnostic algorithm was created by expert consensus. Knowledge gaps were identified as future research directions. Conclusions The guideline committee developed a systematic approach to the diagnosis of HP. The approach should be reevaluated as new evidence accumulates.


Related Papers

No related papers found

Powered by citation graph analysis